Global Markets

Industry still a slave to single source supply, say experts
Global Markets
Industry still a slave to single source supply, say expertsIndustry still a slave to single source supply, say experts

Despite COVID-19 highlighting supply chain issues, biomanufacturers are still using single sources, say experts at BPI West.

byMillie Nelson, Editor
Apr 26, 2023
|
1 Min Read
Pierre Fabre in $618m EGFR deal with Scorpion
Global Markets
Pierre Fabre in $618m EGFR deal with ScorpionPierre Fabre in $618m EGFR deal with Scorpion
byRichard Daverman
Apr 12, 2023
1 Min Read
Sanofi breaks ground on BARDA-supported fill-finish plant
Global Markets
Sanofi breaks ground on BARDA-supported fill-finish plantSanofi breaks ground on BARDA-supported fill-finish plant
byDan Stanton
Apr 6, 2023
1 Min Read
Australian mRNA training center to support Moderna plant
Global Markets
Australian mRNA training center to support Moderna plantAustralian mRNA training center to support Moderna plant
byGareth Macdonald
Apr 3, 2023
1 Min Read
Celltrion eyes US biomanufacturing plant on back of Biden’s Executive Order
Global Markets
Celltrion eyes US biomanufacturing plant on back of Biden’s Executive OrderCelltrion eyes US biomanufacturing plant on back of Biden’s Executive Order
byDan Stanton
Mar 31, 2023
1 Min Read
On the defense: Resilience bags $410m US Gov contract
Global Markets
On the defense: Resilience bags $410m US Gov contractOn the defense: Resilience bags $410m US Gov contract
byDan Stanton
Mar 29, 2023
1 Min Read
Bio-Europe Spring: Lobbyists slam US "Innovation" Reduction Act
Global Markets
Bio-Europe Spring: Lobbyists slam US "Innovation" Reduction Act
Bio-Europe Spring: Lobbyists slam US "Innovation" Reduction Act
Mar 27, 2023
|
1 Min Read
byDan Stanton, Editorial director
There is no quick fix for long-term talent gap issue, say experts
Global Markets
There is no quick fix for long-term talent gap issue, say experts
There is no quick fix for long-term talent gap issue, say experts
Mar 23, 2023
|
1 Min Read
byMillie Nelson, Editor
J&J halts Carvykti UK launch but is manufacturing to blame?
Global Markets
J&J halts Carvykti UK launch but is manufacturing to blame?
J&J halts Carvykti UK launch but is manufacturing to blame?
Mar 21, 2023
|
1 Min Read
byMillie Nelson, Editor
Big Pharma: Biotech partnering will shine amid financial downturn
Global Markets
Big Pharma: Biotech partnering will shine amid financial downturn
Big Pharma: Biotech partnering will shine amid financial downturn
Mar 20, 2023
|
1 Min Read
byDan Stanton, Editorial director
Internal and external investment to grow Moderna beyond COVID
Bioprocess Insider
Internal and external investment to grow Moderna beyond COVID
Internal and external investment to grow Moderna beyond COVID
Feb 28, 2023
|
1 Min Read
byDan Stanton, Editorial director
Seagen rumor mill spins again with Pfizer $30bn+ deal
Bioprocess Insider
Seagen rumor mill spins again with Pfizer $30bn+ deal
Seagen rumor mill spins again with Pfizer $30bn+ deal
Feb 27, 2023
|
1 Min Read
byDan Stanton, Editorial director
The key to plugging CGT talent gaps? Tell kids ‘science is cool’
Global Markets
The key to plugging CGT talent gaps? Tell kids ‘science is cool’
The key to plugging CGT talent gaps? Tell kids ‘science is cool’
Feb 23, 2023
|
1 Min Read
byDan Stanton, Editorial director
Eli Lilly: Capacity and access key to launching Mounjaro outside US
Global Markets
Eli Lilly: Capacity and access key to launching Mounjaro outside US
Eli Lilly: Capacity and access key to launching Mounjaro outside US
Feb 22, 2023
|
1 Min Read
byDan Stanton, Editorial director
The final hurrah? Humira sales hits $21.2 bn in 2022
Global Markets
The final hurrah? Humira sales hits $21.2 bn in 2022
The final hurrah? Humira sales hits $21.2 bn in 2022
Feb 15, 2023
|
1 Min Read
byMillie Nelson, Editor
China to ban export of cutting-edge cell technologies
Global Markets
China to ban export of cutting-edge cell technologies
China to ban export of cutting-edge cell technologies
Feb 9, 2023
|
1 Min Read
byRichard Daverman
Sanofi: ‘Combining biopharma and vaccines ups manufacturing efficiency
Global Markets
Sanofi: ‘Combining biopharma and vaccines ups manufacturing efficiency
Sanofi: ‘Combining biopharma and vaccines ups manufacturing efficiency
Feb 6, 2023
|
1 Min Read
byDan Stanton, Editorial director
Amgen US Humira biosimilar arrives five months ahead of the pack
Global Markets
Amgen US Humira biosimilar arrives five months ahead of the pack
Amgen US Humira biosimilar arrives five months ahead of the pack
Feb 1, 2023
|
1 Min Read
byDan Stanton, Editorial director
Lonza experiences CGT headwinds but hails pipeline for bounce back
Global Markets
Lonza experiences CGT headwinds but hails pipeline for bounce back
Lonza experiences CGT headwinds but hails pipeline for bounce back
Jan 26, 2023
|
1 Min Read
byMillie Nelson, Editor
CDMO GenScript ProBio raises $224m
Global Markets
CDMO GenScript ProBio raises $224m
CDMO GenScript ProBio raises $224m
Jan 23, 2023
|
1 Min Read
byRichard Daverman
Top 10 CGT markers 2022: Approvals aplenty but patient access remains limited
Global Markets
Top 10 CGT markers 2022: Approvals aplenty but patient access remains limited
Top 10 CGT markers 2022: Approvals aplenty but patient access remains limited
Jan 20, 2023
|
1 Min Read
byDan Stanton, Editorial director
Aton Bio: China pharma backed CDMO with a startup spirit
Global Markets
Aton Bio: China pharma backed CDMO with a startup spirit
Aton Bio: China pharma backed CDMO with a startup spirit
Jan 19, 2023
|
1 Min Read
byDan Stanton, Editorial director
Amgen prepped to take first slice of AbbVie’s US Humira pie
Global Markets
Amgen prepped to take first slice of AbbVie’s US Humira pie
Amgen prepped to take first slice of AbbVie’s US Humira pie
Jan 16, 2023
|
1 Min Read
byDan Stanton, Editorial director
WuXi Bio signs $1.5bn TCE antibody pact with GSK
Global Markets
WuXi Bio signs $1.5bn TCE antibody pact with GSK
WuXi Bio signs $1.5bn TCE antibody pact with GSK
Jan 10, 2023
|
1 Min Read
byRichard Daverman
Patient access is political, say CGT experts
Global Markets
Patient access is political, say CGT experts
Patient access is political, say CGT experts
Jan 9, 2023
|
1 Min Read
byMillie Nelson, Editor
Everest starts operations at China mRNA vaccine plant
Global Markets
Everest starts operations at China mRNA vaccine plant
Everest starts operations at China mRNA vaccine plant
Jan 4, 2023
|
1 Min Read
byDan Stanton, Editorial director
2023 predictions: Sustainability, synthetic biology & prepping for the next pandemic
Global Markets
2023 predictions: Sustainability, synthetic biology & prepping for the next pandemic
2023 predictions: Sustainability, synthetic biology & prepping for the next pandemic
Dec 21, 2022
|
1 Min Read
byDan Stanton, Editorial director
Innovative payment models needed for CGT market access, says experts
Global Markets
Innovative payment models needed for CGT market access, says experts
Innovative payment models needed for CGT market access, says experts
Dec 20, 2022
|
1 Min Read
byMillie Nelson, Editor
Digitization: Biopharma must keep up with rest of the world, says Cytiva
Global Markets
Digitization: Biopharma must keep up with rest of the world, says Cytiva
Digitization: Biopharma must keep up with rest of the world, says Cytiva
Dec 19, 2022
|
1 Min Read
byMillie Nelson, Editor
China plant becomes latest in Thermo Fisher biomanufacturing network
Global Markets
China plant becomes latest in Thermo Fisher biomanufacturing network
China plant becomes latest in Thermo Fisher biomanufacturing network
Dec 13, 2022
|
1 Min Read
byDan Stanton, Editorial director
BioProcess Insider State of the Industry — December 2022 Panel Discussion
Global Markets
BioProcess Insider State of the Industry — December 2022 Panel Discussion
BioProcess Insider State of the Industry — December 2022 Panel Discussion
Dec 12, 2022
|
20 Min View
byBPI Contributor
The CDMO space does not have the capacity to meet fill-finish demand, says Lonza
Global Markets
The CDMO space does not have the capacity to meet fill-finish demand, says Lonza
The CDMO space does not have the capacity to meet fill-finish demand, says Lonza
Dec 8, 2022
|
1 Min Read
byMillie Nelson, Editor
COVID cull: Valneva cutting workforce and manufacturing ops
Global Markets
COVID cull: Valneva cutting workforce and manufacturing ops
COVID cull: Valneva cutting workforce and manufacturing ops
Nov 14, 2022
|
1 Min Read
byDan Stanton, Editorial director
Neurophth enters $140m gene therapy collaboration with Cyagen
Global Markets
Neurophth enters $140m gene therapy collaboration with Cyagen
Neurophth enters $140m gene therapy collaboration with Cyagen
Nov 9, 2022
|
1 Min Read
byRichard Daverman
ten23 looks to on-body-injectors to reduce healthcare costs
Global Markets
ten23 looks to on-body-injectors to reduce healthcare costs
ten23 looks to on-body-injectors to reduce healthcare costs
Nov 7, 2022
|
1 Min Read
byMillie Nelson, Editor

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Light Boxes and Beyond: Maximizing Confidence in Clone Selection Using the Beacon Optofluidic System
Register Now: Light Boxes and Beyond: Maximizing Confidence in Clone Selection Using the Beacon Optofluidic System
Insider News
See all
Mar 18 - Mar 21, 2025
SLASH TIME FROM BENCH TO BEDSIDE: Cutting-edge biomanufacturing for mAbs, vaccines, and advanced therapies. Bright ideas, bold science, and big innovations—delivering efficiency, precision, and quality through every phase of bioprocessing.
Learn More

Innovative Technology

Thermo Fisher Scientific peptones white paper
Sponsored Content
The Value of Peptones for Enhancing Biopharmaceutical Productivity
The Value of Peptones for Enhancing Biopharmaceutical Productivity

Jan 27, 2025

Nagase Trehalose SG
Sponsored Content
Innovative Impurity Reduction in Harvesting Process With TREHALOSE SG
Innovative Impurity Reduction in Harvesting Process With TREHALOSE SG

Jan 9, 2025

Bruker Tornado Spectroscopy
Sponsored Content
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy

Dec 1, 2024

Subscribe to receive our monthly print or digital publication
Join our 70,000+ readers. And yes, it's completely free.
Subscribe